ASO Author Reflections: Is There Still a Role for Intraperitoneal Oxaliplatin for Colorectal Peritoneal Metastases?
作者信息
Taibi Abdelkader, Hübner Martin, Eveno Clarisse, Dumont Frederic, Glehen Olivier, Sgarbura Olivia
机构信息
Digestive Surgery Department, Dupuytren Limoges University Hospital, Limoges, France.
CNRS, XLIM, UMR 7252, University Limoges, Limoges, France.
出版信息
Ann Surg Oncol. 2022 Aug;29(8):5252-5253. doi: 10.1245/s10434-022-11657-3. Epub 2022 Mar 30.
PMID:35355127
Abstract
摘要
相似文献
1
ASO Author Reflections: Is There Still a Role for Intraperitoneal Oxaliplatin for Colorectal Peritoneal Metastases?ASO作者反思：奥沙利铂腹腔内给药在结直肠癌腹膜转移中是否仍有作用？
Ann Surg Oncol. 2022 Aug;29(8):5252-5253. doi: 10.1245/s10434-022-11657-3. Epub 2022 Mar 30.
2
ASO Author Reflections: HIPEC Immunogenic Changes Could be Further Exploited by Immunotherapy to Treat Peritoneal Metastases from Colorectal Cancer.ASO作者反思：热灌注化疗的免疫原性变化可通过免疫疗法进一步利用，以治疗结直肠癌的腹膜转移。
Ann Surg Oncol. 2023 May;30(5):2664-2665. doi: 10.1245/s10434-023-13254-4. Epub 2023 Feb 17.
3
ASO Author Reflections: Palliative Management of Peritoneal Metastasis Exploring the Risks and Benefits of CRS/HIPEC, a Distinctly Different Context Than Early CRS/HIPEC Intervention With 'Curative Intent'.ASO作者反思：腹膜转移的姑息治疗——探索CRS/HIPEC的风险与益处，这与具有“治愈意图”的早期CRS/HIPEC干预背景截然不同。
Ann Surg Oncol. 2022 May;29(5):3347-3348. doi: 10.1245/s10434-022-11377-8. Epub 2022 Feb 25.
4
ASO Author Reflections: What is the Best Therapeutic Strategy for Patients with Limited Synchronous Peritoneal Metastases of Colorectal Cancer?ASO作者反思：对于结直肠癌局限性同步腹膜转移患者，最佳治疗策略是什么？
Ann Surg Oncol. 2019 Dec;26(Suppl 3):818. doi: 10.1245/s10434-019-07829-3. Epub 2019 Oct 30.
5
ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases.ASO作者反思：迈向改善细胞减灭术和腹腔热灌注化疗患者的选择：结直肠癌腹膜转移患者预后因素的识别
Ann Surg Oncol. 2018 Dec;25(Suppl 3):840-841. doi: 10.1245/s10434-018-6842-6. Epub 2018 Oct 9.
6
HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?含奥沙利铂 HIPEC 治疗结直肠腹膜转移：路的尽头？
Eur J Surg Oncol. 2019 Mar;45(3):400-402. doi: 10.1016/j.ejso.2018.10.542. Epub 2018 Oct 31.
7
ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases.ASO作者反思：一次有益，两次是否同样有益？对复发性CRS-HIPEC治疗结直肠癌腹膜转移的批判性评估
Ann Surg Oncol. 2021 Sep;28(9):5339-5340. doi: 10.1245/s10434-021-09704-6. Epub 2021 Feb 18.
8
ASO Author Reflections: Biopsychosocial Late Effects are Frequent and Negatively Impact Quality of Life Following Curatively Intended Surgery for Colorectal and Appendiceal Cancer with Peritoneal Metastases.美国外科医师学会作者反思：对于患有腹膜转移的结直肠癌和阑尾癌进行根治性手术后，生物心理社会晚期效应很常见，且对生活质量有负面影响。
Ann Surg Oncol. 2024 Mar;31(3):1696-1697. doi: 10.1245/s10434-023-14727-2. Epub 2023 Dec 10.
9
ASO Author Reflections: Cytoreductive Surgery for Colorectal Peritoneal Metastases-Is It Time to Audit Our Results?ASO作者反思：结直肠癌腹膜转移的减瘤手术——是时候审视我们的结果了吗？
Ann Surg Oncol. 2022 Jan;29(1):203-204. doi: 10.1245/s10434-021-10701-y. Epub 2021 Aug 25.
10
Cytoreduction and hyperthermic intraperitoneal chemotherapy in metastatic colorectal cancer.转移性结直肠癌的细胞减灭术及腹腔内热灌注化疗
J Surg Oncol. 2019 Apr;119(5):613-615. doi: 10.1002/jso.25438. Epub 2019 Mar 10.
引用本文的文献
1
Assessment of Treatment Response after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Appendiceal Peritoneal Metastases.阑尾腹膜转移瘤经腹腔内加压雾化化疗（PIPAC）后治疗反应的评估
Cancers (Basel). 2022 Oct 12;14(20):4998. doi: 10.3390/cancers14204998.
Zotero 插件